SET asks EE to clarify financial statement information Q2/66 within 25 Oct. after reporting loss - contract party does not renew hemp planting contract.

On October 11, 2566 Stock Exchange of Thailand Stated that he would like EE to clarify information in the financial statements for the second quarter of 2 regarding the recording of losses from impairment of goodwill and investments. Including recording an allowance for the reduction in product value in the hemp trading and production business, totaling 2566 million baht, which is the only main business of EE while the parties do not renew the hemp cultivation contract.

In addition, there was a loss from measuring the value of investments in equity securities of listed companies (Unrealized Loss) of another 66 million baht, totaling 160 million baht, resulting in a net loss of 6 million baht for the 2566-month period of 164, affecting operating results. The financial position and liquidity of the company significantly

We request that the information be clarified through the Stock Exchange's information dissemination system by October 25, 2566, and we ask that investors study the EE financial statements and follow the company's explanations.

EE is a Holding Company investing in companies that operate a business of trading and producing hemp. For the 6-month period of 2566, there is an income of 17,800 baht. Summary of information in the financial statements for the 2nd quarter of 2566 As follows:

• Loss from impairment of goodwill and investment in CBD Bioscience Company Limited (CBDB) (occurring 1 year and 1 month after investment) including
  The contracting party did not renew the hemp planting contract worth 88 million baht, including allowance for devaluation of hemp products worth 6 million baht.

In this issue Information in the financial statements Indicates that in the second quarter of 2, the auditor began to have observations on the EE case. Must record loss From the impairment of goodwill and investment in CBDB, including an independent financial advisor who has commented that the purchase price of 2566 million baht of CBDB shares is not appropriate because it is 620% - 22% higher than the appraised price, which shareholders should not. Investment approval While the Board of Directors and the Audit Committee consider that The offer price is appropriate. It is expected to generate income and The profit is higher than the value of the shares purchased. Therefore, investing in CBDB makes sense and is worth the investment.

By further stating that The parties did not renew the hemp cultivation contract with CBDB and another subsidiary operating the same business. There was no impairment recorded on goodwill and investments in the said subsidiary.

• Loss from measuring the value of investments in equity instruments that are listed companies (Unrealized Loss) worth 66 million baht. In this issue, information in the financial statements indicates that the investment value before deducting unrealized loss was 207 million baht. During the period there was an increase in the investment amount. Net 45 million baht

This Issues that the company would like to clarify is item details Impact on the Company's core business operations and operating results and the adequacy of recording the impairment of goodwill and investments in the two subsidiaries. Securities investment policy The opinions of the Board of Directors and the Audit Committee regarding the above matters have been carefully considered in order to avoid any impact on the Company's operating results, liquidity, and financial position.